NCT03062449View on ClinicalTrials.gov

Phase IIa L-serine Trial for eAD

PHASE2TerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

July 20, 2021

Study Completion Date

July 20, 2021

Conditions
Alzheimer Disease
Interventions
DRUG

L-Serine

Gummy containing L serine dose

OTHER

Placebo Gummy

Gummy with no dosing of L Serine

Trial Locations (1)

03756

Dartmouth Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

Brain Chemistry Labs
All Listed Sponsors
collaborator

Brain Chemistry Labs

OTHER

lead

Aleksandra Stark

OTHER